AU2002216341A1 - The use of ecm degrading enzymes for the improvement of cell transplantation - Google Patents

The use of ecm degrading enzymes for the improvement of cell transplantation

Info

Publication number
AU2002216341A1
AU2002216341A1 AU2002216341A AU1634102A AU2002216341A1 AU 2002216341 A1 AU2002216341 A1 AU 2002216341A1 AU 2002216341 A AU2002216341 A AU 2002216341A AU 1634102 A AU1634102 A AU 1634102A AU 2002216341 A1 AU2002216341 A1 AU 2002216341A1
Authority
AU
Australia
Prior art keywords
improvement
cell transplantation
degrading enzymes
ecm degrading
ecm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002216341A
Inventor
Oron Yacoby-Zeevi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Insight Strategy and Marketing Ltd
Original Assignee
Insight Strategy and Marketing Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insight Strategy and Marketing Ltd filed Critical Insight Strategy and Marketing Ltd
Publication of AU2002216341A1 publication Critical patent/AU2002216341A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/0105—Alpha-N-acetylglucosaminidase (3.2.1.50)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01035—Hyaluronoglucosaminidase (3.2.1.35), i.e. hyaluronidase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01128—Glycyrrhizinate beta-glucuronidase (3.2.1.128), i.e. GL beta-D-glucoronidase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01166—Heparanase (3.2.1.166)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AU2002216341A 2000-12-19 2001-12-17 The use of ecm degrading enzymes for the improvement of cell transplantation Abandoned AU2002216341A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25634700P 2000-12-19 2000-12-19
US60/256,347 2000-12-19
PCT/IL2001/001169 WO2002050243A2 (en) 2000-12-19 2001-12-17 The use of ecm degrading enzymes for the improvement of cell transplantation

Publications (1)

Publication Number Publication Date
AU2002216341A1 true AU2002216341A1 (en) 2002-07-01

Family

ID=22971908

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002216341A Abandoned AU2002216341A1 (en) 2000-12-19 2001-12-17 The use of ecm degrading enzymes for the improvement of cell transplantation

Country Status (6)

Country Link
US (1) US20040033218A1 (en)
EP (1) EP1379139A4 (en)
JP (1) JP2005500977A (en)
AU (1) AU2002216341A1 (en)
CA (1) CA2432157A1 (en)
WO (1) WO2002050243A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070053884A1 (en) * 2003-05-16 2007-03-08 Kyowa Hakko Kogyo Co., Ltd Novel adult tissue-derived stem cell and use thereof
CA2594013A1 (en) * 2005-01-12 2006-07-20 Massachusetts Institute Of Technology Methods and compositions related to modulating the extracellular stem cell environment
WO2008124494A1 (en) * 2007-04-03 2008-10-16 The Cleveland Clinic Foundation Enrichment of tissue-derived adult stem cells based on retained extracellular matrix material
US20160017302A1 (en) * 2013-03-05 2016-01-21 Baylor College Of Medicine Heparanase expression in human t lymphocytes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US6153187A (en) * 1997-09-02 2000-11-28 Insight Strategy & Marketing Ltd. Use of glycosaminoglycans degrading enzymes for management of airway associated diseases
US6177545B1 (en) * 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
US5968822A (en) * 1997-09-02 1999-10-19 Pecker; Iris Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
US6348344B1 (en) * 1997-09-02 2002-02-19 Insight Strategy & Marketing Ltd. Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same
US20010006630A1 (en) * 1997-09-02 2001-07-05 Oron Yacoby-Zeevi Introducing a biological material into a patient
US6190875B1 (en) * 1997-09-02 2001-02-20 Insight Strategy & Marketing Ltd. Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe
BR9813296A (en) * 1997-10-28 2000-08-22 Univ Australian Isolated nucleic acid molecule, process for identifying a nucleic acid molecule encoding a mammalian endoglucuronidase polypeptide, expression vector, isolated heparanase peptide, recombinant or isolated polypeptide, antibody molecule, process for identifying a modulator of heparanase activity, use of a sulfated oligosaccharide, a sulfonate or hspg comprising the same, processes for treating a physiological or medical condition in a human or animal subject in which the heparanase activity in that subject is high, to intensify the healing of wounds in a subject human or animal and to diagnose a physiological or medical condition associated with overexpression of heparanase, e, cell
AU1864999A (en) * 1997-12-15 1999-07-05 Universite Laval Methods and compositions for improving the success of cell transplantation in a host
WO2000052178A1 (en) * 1999-03-01 2000-09-08 Insight Strategy & Marketing Ltd. Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
EP1333862A4 (en) * 2000-10-17 2004-08-18 Insight Strategy & Marketing Methods of and pharmaceutical compositions for improving implantation of embryos

Also Published As

Publication number Publication date
WO2002050243A3 (en) 2003-10-30
JP2005500977A (en) 2005-01-13
WO2002050243A2 (en) 2002-06-27
EP1379139A2 (en) 2004-01-14
US20040033218A1 (en) 2004-02-19
CA2432157A1 (en) 2002-06-27
EP1379139A4 (en) 2004-12-01

Similar Documents

Publication Publication Date Title
AU2001294671A1 (en) Microfabrication of membranes for the growth of cells
AU5090200A (en) Culture chamber
AU2002220082A1 (en) Imaging of enzymatic activity
AU6633401A (en) Gasket for fuel cell
AU2002225997A1 (en) Two chamber cell culture vessel
EP1130098A3 (en) Mammalian osteoregulins
AU2001267333A1 (en) Lipolytic enzyme
AU2002242633A1 (en) Fermentation process including the use of enzymes
AU1878601A (en) Enzyme
AUPQ346399A0 (en) Stable idle procedure
AU2001235452A1 (en) Cell culture media
AU2002325758A1 (en) Cultured stromal cells and uses thereof
AU2002220553A1 (en) Bioreactor
AU2001280149A1 (en) Stem cell culture medium and culture method by using the same
AU2002221665A1 (en) Garage shaped biogas fermenter for the methanisation of biomasse
AU2001278734A1 (en) Method of extensive culture of antigen-specific cytotoxic t cells
AU2001233502A1 (en) Pancreatic islet cell growth factors
AU7125700A (en) Enzyme inhibitors
AU2203901A (en) Microporous membrane
AU2001275897A1 (en) Improvement of cell culture performance
AU4081900A (en) Porous membrane
AU2002216341A1 (en) The use of ecm degrading enzymes for the improvement of cell transplantation
AU7127000A (en) Enzyme inhibitors
GB9904773D0 (en) Culture of mycobacteria
AU2001237592A1 (en) Enzymes and uses relating thereto